Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Total Artificial Heart - Medical Devices Pipeline Assessment, 2016

Be the first to review this product

Total Artificial Heart - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, 'Total Artificial Heart - Medical Devices Pipeline Assessment, 2016' provides...
You can choose to pay by purchase order during checkout

Availability: In stock

$2,500.00

* Required Fields

You can choose to pay by purchase order during checkout
GlobalData.

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

Total Artificial Heart - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, 'Total Artificial Heart - Medical Devices Pipeline Assessment, 2016' provides an overview of Total Artificial Heart currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Total Artificial Heart pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type

Scope

- Extensive coverage of the Total Artificial Heart under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Total Artificial Heart and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Total Artificial Heart under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Additional Information

Additional Information

Publisher name GlobalData.
Format PDF
Page count 46
Publication date 1 Jun 2016
Table of contents 1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Total Artificial Heart Overview 6
3 Products under Development 7
3.1 Total Artificial Heart - Pipeline Products by Stage of Development 7
3.2 Total Artificial Heart - Pipeline Products by Territory 8
3.3 Total Artificial Heart - Pipeline Products by Regulatory Path 9
3.4 Total Artificial Heart - Pipeline Products by Estimated Approval Date 10
3.5 Total Artificial Heart - Ongoing Clinical Trials 11
4 Total Artificial Heart - Pipeline Products under Development by Companies 12
4.1 Total Artificial Heart Companies - Pipeline Products by Stage of Development 12
4.2 Total Artificial Heart - Pipeline Products by Stage of Development 13
5 Total Artificial Heart Companies and Product Overview 14
5.1 Abiomed, Inc. Company Overview 14
5.1.1 Abiomed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 BiVacor Pty Ltd Company Overview 16
5.2.1 BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 Carmat SAS Company Overview 17
5.3.1 Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 Cleveland Heart, Inc. Company Overview 21
5.4.1 Cleveland Heart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 Foster-Miller, Inc. (Inactive) Company Overview 23
5.5.1 Foster-Miller, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 MicroMed Cardiovascular, Inc. Company Overview 24
5.6.1 MicroMed Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.7 SynCardia Systems, Inc. Company Overview 25
5.7.1 SynCardia Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.8 The University of Tokyo Company Overview 34
5.8.1 The University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview 34
6 Total Artificial Heart- Recent Developments 35
6.1 Apr 13, 2016: World's Leading Artificial Heart Center, La Piti_ Hospital, Paris, Celebrates 30 Years and 249 Implants of the SynCardia Total Artificial Heart 35
6.2 Feb 29, 2016: Early Findings of the 50cc SynCardia Heart Indicate That It Fits Underserved Patients - Women & Adolescents 36
6.3 Feb 26, 2016: Carmat Raises USD55 Million in Private Placement of Shares 37
6.4 Jan 26, 2016: Altaris Capital Partners Acquires Minority Interest in Minnetronix for USD20 Million 37
6.5 Jan 21, 2016: Information regarding the Feasibility study of the CARMAT bioprosthetic artificial heart 37
6.6 Nov 12, 2015: Arrhythmia Research Technology Reports 2015 Third Quarter Results 38
6.7 Sep 16, 2015: SynCardia Systems Withdraws IPO for up to USD30 Million 39
6.8 Aug 31, 2015: Interim Results of the Feasibility Study Presented at the ESC Congress in London 40
6.9 Aug 18, 2015: The Start of SynCardia Total Artificial Heart Destination Clinical Study Wins Edison Awards' Top Honor 40
6.10 Jun 15, 2015: SynCardia Systems - TAH-t Companion 2 Driver System - Letter to Health Care Providers 41
6.11 Jun 03, 2015: Carmat To Implant Artificial Heart In Fourth Patient In Next Three Months 42
7 Appendix 43
7.1 Methodology 43
7.2 About GlobalData 45
7.3 Contact Us 46
7.4 Disclaimer 46

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.